But imagine a different scenario, where we could have had an array, a genetically diverse array, of cardiac cells, and we could have actually tested that drug, Vioxx, in petri dishes, and figured out, well, okay, people with this genetic type are going to have cardiac side effects, people with these genetic subgroups or genetic shoes sizes, about 25,000 of them, are not going to have any problems.
但是我们来设想一下另一种情形， 如果我们之前能有心脏细胞的各种基因阵列， 并且已经实际测试过这种药物， 在培养皿中实际测试过Vioxx， 知道某一种遗传类型的人会出现 心脏方面的副作用，而另一些遗传亚型 或遗传“鞋号“的人——大约有2万5千个， 不会出现任何问题。